Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer.

Kohei NakachiMasaru KonishiMasafumi IkedaKazuaki ShimadaTakuji OkusakaAkio SaiuraHiroshi IshiiMasanori SugiyamaJunji FuruseHirohiko SakamotoTomotaka ShimamuraTakehiro Ohta

Published in: International journal of clinical oncology (2018)

Adjuvant chemotherapy with S-1 is feasible treatment in patients with resected biliary tract cancer. It is necessary to conduct a phase III study to confirm the efficacy of adjuvant therapy of S-1 in patients with resected BTC.

Keyphrases

phase iii
papillary thyroid
squamous cell
lymph node
clinical trial
open label
patients undergoing
lymph node metastasis
squamous cell carcinoma
prognostic factors
phase ii
young adults
replacement therapy
smoking cessation